Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndrome
- PMID: 23182990
- PMCID: PMC4855504
- DOI: 10.1200/JCO.2012.42.9241
Development of a plaque infiltrated with large CD30+ T cells over a silicone-containing device in a patient with history of Sézary syndrome
Similar articles
-
CD30+ leukemic cutaneous T-cell lymphoma.J Am Acad Dermatol. 2021 Feb;84(2):530-532. doi: 10.1016/j.jaad.2020.05.014. Epub 2020 May 11. J Am Acad Dermatol. 2021. PMID: 32437721 No abstract available.
-
Upregulation of inhibitory signaling receptor programmed death marker-1 (PD-1) in disease evolution from cutaneous lymphoid dyscrasias to mycosis fungoides and Sezary's syndrome.Ann Diagn Pathol. 2017 Jun;28:54-59. doi: 10.1016/j.anndiagpath.2017.02.003. Epub 2017 Feb 10. Ann Diagn Pathol. 2017. PMID: 28648940
-
Brentuximab-induced splinter nail haemorrhages in a patient with Sézary syndrome: A case report.Br J Clin Pharmacol. 2022 Aug;88(8):3883-3886. doi: 10.1111/bcp.15247. Epub 2022 Feb 8. Br J Clin Pharmacol. 2022. PMID: 35088431
-
Autoimmune hemolytic anemia presenting in Sézary syndrome. Report of a case and review of the literature.Acta Haematol. 1992;88(1):46-9. doi: 10.1159/000204595. Acta Haematol. 1992. PMID: 1414162 Review.
-
Drug-induced pseudo-Sezary syndrome: a case report and literature review.Am J Dermatopathol. 2015 Jan;37(1):83-6. doi: 10.1097/DAD.0000000000000169. Am J Dermatopathol. 2015. PMID: 25033012 Review.
Cited by
-
Comprehensive Evaluation of the Current Knowledge on Breast Implant Associated-Anaplastic Large Cell Lymphoma.Arch Plast Surg. 2022 Apr 6;49(2):141-149. doi: 10.1055/s-0042-1744422. eCollection 2022 Mar. Arch Plast Surg. 2022. PMID: 35832665 Free PMC article.
-
The State of the Art about Etiopathogenetic Models on Breast Implant Associated-Anaplastic Large Cell Lymphoma (BIA-ALCL): A Narrative Review.J Clin Med. 2021 May 12;10(10):2082. doi: 10.3390/jcm10102082. J Clin Med. 2021. PMID: 34066230 Free PMC article. Review.
-
Etiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL): Current Directions in Research.Cancers (Basel). 2020 Dec 21;12(12):3861. doi: 10.3390/cancers12123861. Cancers (Basel). 2020. PMID: 33371292 Free PMC article. Review.
-
Finding Consensus After Two Decades of Breast Implant-Associated Anaplastic Large Cell Lymphoma.Semin Plast Surg. 2019 Nov;33(4):270-278. doi: 10.1055/s-0039-1696998. Epub 2019 Oct 17. Semin Plast Surg. 2019. PMID: 31632211 Free PMC article. Review.
References
-
- US Food and Drug Administration Center for Devices and Radiological Health: FDA medical device safety communication: Reports of anaplastic large cell lymphoma (ALCL) in women with breast implants, 2011. http://www.fda.gov/MedicalDevices/Safety/alertsandNotices/ucm240000.htm.
-
- Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol. 2002;46:95–106. - PubMed
-
- Greer JP, Salhany KE, Cousar JB, et al. Clinical features associated with transformation of cerebriform T-cell lymphoma to a large cell process. Hematol Oncol. 1990;8:215–227. - PubMed
-
- Diamandidou E, Colome-Grimmer M, Fayad L, et al. Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis. Blood. 1998;92:1150–1159. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical